Citadel Advisors
CLPT icon

Citadel Advisors’s ClearPoint Neuro CLPT Stock Holding History

Citadel Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$869K Buy
+48,688
New +$608K ﹤0.01% 8560
2026
Q1 		– Sell
-43,364
Closed -$548K – 13117
2025
Q4 		$593K Sell
43,364
-43,128
-50% -$799K ﹤0.01% 8621
2025
Q3 		$1.88M Buy
86,492
+6,923
+9% +$81.6K ﹤0.01% 6186
2025
Q2 		$950K Buy
79,569
+67,360
+552% +$848K ﹤0.01% 7217
2025
Q1 		$145K Sell
12,209
-12,969
-52% -$202K ﹤0.01% 10927
2024
Q4 		$387K Sell
25,178
-60,736
-71% -$787K ﹤0.01% 9123
2024
Q3 		$963K Sell
85,914
-99,078
-54% -$949K ﹤0.01% 6943
2024
Q2 		$997K Buy
184,992
+110,216
+147% +$638K ﹤0.01% 6581
2024
Q1 		$508K Buy
74,776
+46,759
+167% +$327K ﹤0.01% 8363
2023
Q4 		$190K Sell
28,017
-58,191
-68% -$329K ﹤0.01% 10031
2023
Q3 		$432K Sell
86,208
-17,706
-17% -$105K ﹤0.01% 8391
2023
Q2 		$752K Buy
103,914
+29,976
+41% +$255K ﹤0.01% 7047
2023
Q1 		$624K Sell
73,938
-51,002
-41% -$447K ﹤0.01% 7839
2022
Q4 		$1.06M Buy
124,940
+98,165
+367% +$930K ﹤0.01% 6711
2022
Q3 		$277K Sell
26,775
-8,342
-24% -$110K ﹤0.01% 9742
2022
Q2 		$458K Buy
+35,117
New +$359K ﹤0.01% 8838
2022
Q1 		– Sell
-31,995
Closed -$291K – 13685
2021
Q4 		$359K Sell
31,995
-10,233
-24% -$153K ﹤0.01% 10503
2021
Q3 		$750K Buy
42,228
+1,728
+4% +$32.4K ﹤0.01% 8870
2021
Q2 		$773K Buy
+40,500
New +$783K ﹤0.01% 9032
2019
Q4 		– Sell
-10,268
Closed -$52K – 9168
2019
Q3 		$52K Buy
+10,268
New +$42.1K ﹤0.01% 8687

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Citadel Advisors's CLPT Position: Q2 2026 in Review

Citadel Advisors opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 48,688 shares worth $869K. The stake represents ﹤0.01% of the portfolio and ranks #8560 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CLPT as recently as Q4 2025.

Citadel Advisors first reported a position in CLPT in Q3 2019 and has held it in 20 quarters since. The position peaked at $1.88M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Citadel Advisors held 48,688 shares of ClearPoint Neuro worth $869K as of Q2 2026.
  • ClearPoint Neuro was a new Citadel Advisors position in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8560 holding.
  • Citadel Advisors first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 20 quarters since.
  • Citadel Advisors's ClearPoint Neuro position peaked at $1.88M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.